drugset / Trial / NCT02854371

Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI

NCT02854371 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

Liver function is a key factor that can help predict the clinical outcome in patients with cirrhosis. Traditionally, liver function was measured using either indocyanine green (ICG) or other radionucleotides. Recently, gadoxetic acid has been reported to show liver function in several studies. There have been several approaches to measure liver function using gadoxetic acid, and hepatocyte fraction is one of the promising methods. Since gadoxetic acid enhanced liver MRI is clinically used world widely, it would be valuable if we can measure liver function using hepatocyte fraction.

Timeline

Start
2016-08
Primary completion
2017-02
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Subject GADOXETIC ACID Diagnostic / imaging agent 0.025 unknown Intravenous

Indications